Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Sunshine Biopharma, Inc. (NASDAQ: SBFM)
SBFM Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-5.50%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
SBFM Stock Analysis
SBFM
PE Ratio:
SBFM
PEG Ratio:
Not Available
SBFM
Forward EPS Growth (12 month):
0.00%
SBFM
PS Ratio:
SBFM
PSG Ratio:
Not Available
SBFM
Forward Revenue Growth (12 month):
0.00%
SBFM Articles
No data was found